Literature DB >> 33687287

Cerebrovascular Reactivity Mapping Using Resting-State BOLD Functional MRI in Healthy Adults and Patients with Moyamoya Disease.

Peiying Liu1, Gongkai Liu1, Marco C Pinho1, Zixuan Lin1, Binu P Thomas1, Melissa Rundle1, Denise C Park1, Judy Huang1, Babu G Welch1, Hanzhang Lu1.   

Abstract

Background Cerebrovascular reserve, the potential capacity of brain tissue to receive more blood flow when needed, is a desirable marker in evaluating ischemic risk. However, current measurement methods require acetazolamide injection or hypercapnia challenge, prompting a clinical need for resting-state (RS) blood oxygen level-dependent (BOLD) functional MRI data to measure cerebrovascular reactivity (CVR). Purpose To optimize and evaluate an RS CVR MRI technique and demonstrate its relationship to neurosurgical treatment. Materials and Methods In this HIPAA-compliant study, RS BOLD functional MRI data collected in 170 healthy controls between December 2008 and September 2010 were retrospectively evaluated to identify the optimal frequency range of temporal filtering on the basis of spatial correlation with the reference standard CVR map obtained with CO2 inhalation. Next, the optimized RS method was applied in a new, prospective cohort of 50 participants with Moyamoya disease who underwent imaging between June 2014 and August 2019. Finally, CVR values were compared between brain hemispheres with and brain hemispheres without revascularization surgery by using Mann-Whitney U test. Results A total of 170 healthy controls (mean age ± standard deviation, 51 years ± 20; 105 women) and 100 brain hemispheres of 50 participants with Moyamoya disease (mean age, 41 years ± 12; 43 women) were evaluated. RS CVR maps based on a temporal filtering frequency of [0, 0.1164 Hz] yielded the highest spatial correlation (r = 0.74) with the CO2 inhalation CVR results. In patients with Moyamoya disease, 77 middle cerebral arteries (MCAs) had stenosis. RS CVR in the MCA territory was lower in the group that did not undergo surgery (n = 30) than in the group that underwent surgery (n = 47) (mean, 0.407 relative units [ru] ± 0.208 vs 0.532 ru ± 0.182, respectively; P = .006), which is corroborated with the CO2 inhalation CVR data (mean, 0.242 ru ± 0.273 vs 0.437 ru ± 0.200; P = .003). Conclusion Cerebrovascular reactivity mapping performed by using resting-state blood oxygen level-dependent functional MRI provided a task-free method to measure cerebrovascular reserve and depicted treatment effect of revascularization surgery in patients with Moyamoya disease comparable to that with the reference standard of CO2 inhalation MRI. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Wolf and Ware in this issue.

Entities:  

Mesh:

Year:  2021        PMID: 33687287      PMCID: PMC8108558          DOI: 10.1148/radiol.2021203568

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  25 in total

1.  Novel magnetic resonance angiography stage grading for moyamoya disease.

Authors:  Kiyohiro Houkin; Naoki Nakayama; Satoshi Kuroda; Tadashi Nonaka; Takaharu Shonai; Takashi Yoshimoto
Journal:  Cerebrovasc Dis       Date:  2005-08-30       Impact factor: 2.762

2.  In vivo flow territory mapping of major brain feeding arteries.

Authors:  Peter Jan van Laar; Jeroen Hendrikse; Xavier Golay; Hanzhang Lu; Matthias J P van Osch; Jeroen van der Grond
Journal:  Neuroimage       Date:  2005-08-10       Impact factor: 6.556

3.  Consistent resting-state networks across healthy subjects.

Authors:  J S Damoiseaux; S A R B Rombouts; F Barkhof; P Scheltens; C J Stam; S M Smith; C F Beckmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

4.  Measuring vascular reactivity with resting-state blood oxygenation level-dependent (BOLD) signal fluctuations: A potential alternative to the breath-holding challenge?

Authors:  Hesamoddin Jahanian; Thomas Christen; Michael E Moseley; Nicholas M Pajewski; Clinton B Wright; Manjula K Tamura; Greg Zaharchuk
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

5.  Cerebrovascular reactivity mapping using intermittent breath modulation.

Authors:  Peiying Liu; Cuimei Xu; Zixuan Lin; Sandeepa Sur; Yang Li; Sevil Yasar; Paul Rosenberg; Marilyn Albert; Hanzhang Lu
Journal:  Neuroimage       Date:  2020-04-08       Impact factor: 6.556

6.  Cerebrovascular reactivity mapping without gas challenges.

Authors:  Peiying Liu; Yang Li; Marco Pinho; Denise C Park; Babu G Welch; Hanzhang Lu
Journal:  Neuroimage       Date:  2016-11-23       Impact factor: 6.556

7.  Cerebral blood flow modulation insufficiency in brain networks in multiple sclerosis: A hypercapnia MRI study.

Authors:  Olga Marshall; Sanjeev Chawla; Hanzhang Lu; Louise Pape; Yulin Ge
Journal:  J Cereb Blood Flow Metab       Date:  2016-06-15       Impact factor: 6.200

8.  Cerebral blood flow, transit time, and apparent diffusion coefficient in moyamoya disease before and after acetazolamide.

Authors:  Christian Federau; Soren Christensen; Zungho Zun; Sun-Won Park; Wendy Ni; Michael Moseley; Greg Zaharchuk
Journal:  Neuroradiology       Date:  2016-12-02       Impact factor: 2.804

9.  Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study.

Authors:  Kuniaki Ogasawara; Akira Ogawa; Takashi Yoshimoto
Journal:  Stroke       Date:  2002-07       Impact factor: 7.914

10.  On the assessment of cerebrovascular reactivity using hypercapnia BOLD MRI.

Authors:  Uma S Yezhuvath; Kelly Lewis-Amezcua; Rani Varghese; Guanghua Xiao; Hanzhang Lu
Journal:  NMR Biomed       Date:  2009-08       Impact factor: 4.044

View more
  5 in total

1.  Non-contrast hemodynamic imaging of Moyamoya disease with MR fingerprinting ASL: A feasibility study.

Authors:  Pan Su; Peiying Liu; Marco C Pinho; Binu P Thomas; Ye Qiao; Judy Huang; Babu G Welch; Hanzhang Lu
Journal:  Magn Reson Imaging       Date:  2022-02-18       Impact factor: 2.546

2.  Quantitative cerebrovascular reactivity MRI in mice using acetazolamide challenge.

Authors:  Zhiliang Wei; Yuguo Li; Xirui Hou; Zheng Han; Jiadi Xu; Michael T McMahon; Wenzhen Duan; Guanshu Liu; Hanzhang Lu
Journal:  Magn Reson Med       Date:  2022-06-17       Impact factor: 3.737

3.  Editorial for "Pre-Surgical Magnetic Resonance Imaging Indicators of Revascularization Response in Adults With Moyamoya Vasculopathy".

Authors:  Yibin Xie
Journal:  J Magn Reson Imaging       Date:  2022-03-17       Impact factor: 5.119

4.  CVR-MRICloud: An online processing tool for CO2-inhalation and resting-state cerebrovascular reactivity (CVR) MRI data.

Authors:  Peiying Liu; Zachary Baker; Yue Li; Yang Li; Jiadi Xu; Denise C Park; Babu G Welch; Marco Pinho; Jay J Pillai; Argye E Hillis; Susumu Mori; Hanzhang Lu
Journal:  PLoS One       Date:  2022-09-28       Impact factor: 3.752

5.  Hemodynamic evaluation of patients with Moyamoya Angiopathy: comparison of resting-state fMRI to breath-hold fMRI and [15O]water PET.

Authors:  Leonie Zerweck; Constantin Roder; Till-Karsten Hauser; Johannes Thurow; Annerose Mengel; Marcos Tatagiba; Nadia Khan; Philipp T Meyer; Ulrike Ernemann; Uwe Klose
Journal:  Neuroradiology       Date:  2021-09-27       Impact factor: 2.804

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.